By THE ASSOCIATED PRESS
The first combination of drugs to bolster the immune system to fight cancer has been approved, giving Bristol-Myers Squibb an early lead over competitors.
Published: October 2, 2015 at 12:00AM
from NYT Business Day http://ift.tt/1O74mP8
from WordPress http://ift.tt/1KYmQfq
via Hadi Aboukhater
No comments:
Post a Comment